Leaders from across Arizona will be sharing insights on stage at BIO 2014 in San Diego.Continue reading
CFAST Sparks Pathways for Developing New Therapeutics for Unmet Patient Needs. Development of Standards Aid FDA in Meeting Commitments under PDUFA V.Continue reading
In a big step forward for Alzheimer’s disease (AD) therapy development, both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have independently reached favorable decisions on the value of Critical Path Institute’s new disease simulation tool for improving trial design in mild and moderate Alzheimer’s disease. The first such instrument to ever receive this regulatory designation, the tool represents an enabling advance to improve the design of future clinical trials in AD. The new tool applies computerized models to simulate “what-if” scenarios for clinical trials.
The goal of this virtual tool is to serve as a public resource for sponsors designing trials of new therapies for AD.Continue reading
Dr. John-Michael Sauer, a 15-year veteran of pharmaceutical research and development, will lead the Predictive Safety Testing ConsortiumContinue reading
Global Cancer Diagnostics, Inc.(Tempe, Arizona), The Critical Path Institute (Tucson, Arizona and Rockville, Maryland) and Ulthera, Inc.(Mesa, Arizona) announced as 2012 AZBio Fast Lane Award Winners.Continue reading
Tucson, Arizona, March 25, 2012 – Critical Path Institute (C-Path) welcomes four new board members who were recently elected to serve three-year terms (2012-2015). Continue reading
Students and Faculty on the biosciences – did you know that the same federal agencies (like DOD, NIH and NSF) that funded your initial research may provide you with grants of up to $100,000 (phase 1) and $1 million (phase 2) to commercialize that very same research under the $2.5 billion federal SBIR program awarded annually. The federal government desperately needs entrepreneurial researchers to create jobs over the next ten years to solve the country’s economic problems, and will support those researchers that show they can do it with SBIR funding (and other new major research commercialization programs now under consideration by the federal government). Researchers who can commercialize research are in great demand.
Are they looking for you?Continue reading
On April 11, 2011, The AZBio community and Arizona lawmakers came together to connect, engage and share ideas on how to combine Business + BioScience for a Better Arizona.
The informational event, supported by BIO and the Arizona Science Center and hosted by AZBIO, included updates from Walt Plosila of Battelle on the Arizona BioScience Road Map and how our bioscience community is creating more quality jobs in Arizona followed by a look into innovations and collaborations that are happening at the Critical Path Institute (C-Path) in Tucson by C-Path founder and internationally recognized leader on the art and science of moving bioscience innovations forward – Dr. Raymond Woosley.
Throughout the evening, AZBio members from across our state shared ideas, new developments, as well as success stories with each other and with our Arizona Lawmakers. Then together we all were dazzled by the incredible Body Worlds and the Brain exhibit at the Arizona Science Center.Continue reading